AMOXICILLIN | A061926 | TEVA PHARMACEUTICALS USA INC
Total Spending
$34.4M
Total Claims
9,026,776
Beneficiaries
6,202,496
Avg Cost/Unit
$0.19
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
11 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
No patent or exclusivity listings for this strength.